Average Co-Inventor Count = 2.49
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vegenics Pty Limited (4 from 22 patents)
2. Licentia, Ltd. (3 from 20 patents)
3. Ludwig Institute for Cancer Research Limited (2 from 525 patents)
4. Vegenics Limited (2 from 19 patents)
5. Ludwig Institute of Cancer Research (1 from 3 patents)
6. Vengenics Limited (1 from 1 patent)
7. Seppo Yla-Herttuala (1 from 1 patent)
10 patents:
1. 8455453 - Use of VEGF-D gene to prevent restenosis
2. 8278098 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
3. 8025886 - Modified VEGF-A with improved angiogenic properties
4. 7902149 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
5. 7855178 - Growth factor binding constructs materials and methods
6. 7566566 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
7. 7422741 - VEGFR-3 fusion proteins
8. 7309604 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
9. 6965010 - Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10. 6958147 - Use of VEGF-C to prevent restenosis